Trial intelligence / Profile preview

Iron-containing vs non-iron phosphate binder in maintenance hemodialysis (ICBP study)

jRCTs051190013Completed

Sponsor
Kissei Pharmaceutical Co., Ltd.
Start
May 2017
Countries
1
01

Overview

Trial in chronic kidney disease (CKD) and hyperphosphatemia (2 arms), sponsored by Kissei Pharmaceutical Co., Ltd. Primary endpoint: Adverse events and survival. Started May 2017; status: completed.

02

Conditions

chronic kidney disease (CKD)hyperphosphatemia

Beyond the preview

Go deeper on jRCTs051190013.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs051190013.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call